Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

13 Apr 2011 14:21

RNS Number : 8566E
Croda International PLC
13 April 2011
 



Croda International Plc

 

13 April 2011

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

 

In accordance with Disclosure Rule 3.1.4R(1), I hereby inform you that Croda International Plc ("the Company") was notified on 13 April 2011, that the following transactions took place in relation to the Croda International Plc Share Incentive Plan ("SIP") on 11 April 2011. The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 10p each, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ("matching shares").

 

1.

The SIP trustee (Capita IRG Trustees Limited) acquired 3,208 ordinary shares by purchase in the market on 11 April 2011 at a total cost of £56,779.45 and allocated them to employees participating in the SIP as partnership shares.

 

2.

The SIP trustee (Capita IRG Trustees Limited) also acquired 3,208 ordinary shares by purchase in the market on 11 April 2011 at a total cost of £56,779.45 and allocated them to employees participating in the SIP as matching shares.

 

3.

The following directors and persons discharging managerial responsibilities purchased the number of ordinary shares of 10p set out against their names below, at a price of 1755p per ordinary share, and were allocated for no consideration the number of matching shares set out against their names below:

 

Name

Role

 

 

Number of ordinary

shares purchased

Number of matching

shares allocated

M Humphrey

Executive Director

7

7

M S Christie

Executive Director

7

7

S E Foots

Executive Director

7

7

D E Barraclough

PDMR

7

7

K Layden

PDMR

7

7

G L Myers

PDMR

7

7

K M Nutbrown

PDMR

7

7

A L Scott

PDMR

7

7

 

This notification is made in order to satisfy both section 793 of the Companies Act 2006 and Disclosure and Transparency Rule 3.1.2.

 

 

 

 

Louise Scott

Company Secretary and Legal Counsel

Croda International Plc

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXXLFFFZFLBBB
Date   Source Headline
11th Jan 20233:45 pmRNSDirector/PDMR Shareholding
13th Dec 20223:04 pmRNSDirector/PDMR Shareholding
6th Dec 202212:36 pmRNSDirector/PDMR Shareholding
14th Nov 20223:33 pmRNSHolding(s) in Company
11th Nov 20222:04 pmRNSDirector/PDMR Shareholding
11th Nov 202210:37 amRNSDirector/PDMR Shareholding
11th Nov 202210:33 amRNSDirector/PDMR Shareholding
8th Nov 202211:23 amRNSDirector/PDMR Shareholding
7th Nov 20226:11 pmRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSJez Maiden to retire as Group Finance Director
3rd Nov 20225:53 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:50 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:49 pmRNSDirector/PDMR Shareholding
11th Oct 20221:37 pmRNSDirector/PDMR Shareholding
7th Oct 20228:37 amRNSDirector/PDMR Shareholding
7th Oct 20227:59 amRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSInvestor seminar
5th Oct 20224:42 pmRNSDirector/PDMR Shareholding
20th Sep 20229:01 amRNSDirector/PDMR Shareholding
13th Sep 20221:47 pmRNSDirector/PDMR Shareholding
11th Aug 20222:39 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSResults for the six months ended 30 June 2022
22nd Jul 20224:50 pmRNSDirectorate Change
12th Jul 20223:08 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSCompleted divestment
30th Jun 202212:15 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSUS Government to support lipid systems expansion
22nd Jun 20229:07 amRNSHolding(s) in Company
17th Jun 20229:46 amRNSHolding(s) in Company
13th Jun 20222:52 pmRNSDirector/PDMR Shareholding
8th Jun 202211:53 amRNSDirector/PDMR Shareholding
7th Jun 20225:23 pmRNSTransaction in Own Shares
7th Jun 20224:08 pmRNSDirector/PDMR Shareholding
7th Jun 20223:27 pmRNSHolding(s) in Company
27th May 202210:48 amRNSHolding(s) in Company
26th May 20227:02 amRNSDirector Declaration
23rd May 20222:34 pmRNSResult of AGM
20th May 20227:21 amRNSAGM trading update
19th May 20223:09 pmRNSDirector/PDMR Shareholding
19th May 20222:17 pmRNSHolding(s) in Company
11th May 20222:15 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSSite visit and investor presentation
3rd May 202210:21 amRNSDirector/PDMR Shareholding
13th Apr 20229:48 amRNSDirector/PDMR Shareholding
7th Apr 20226:15 pmRNSDirector/PDMR Shareholding
31st Mar 20223:12 pmRNSUK Government to support lipid systems expansion
29th Mar 20227:00 amRNSInvestor seminar
22nd Mar 20226:14 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.